WHY AMI IS THE ONLY NAME TO TRUST FOR A BETTER SEX LIFE
MI has developed effective treatment options to improve sexual health for over 20+ years & 500,000 patients.
iscreet, reliable & effective consultations and medications to put you back in action
alue Added Global presence –to ensure fast relief -for all kinds of Sexual Dysfunction.
sk us for our Proven Treatment Options for Erectile Dysfunction & Premature Ejaculation
asal Delivery Technology and Oral Strip Technology –to ensure Fast onset of Action
ost Effective Medical Solutions –to Make you Last Longer.
ffective, Verified & Time Tested Medically Backed Results
edication to Quality Assurance for past two decades
edical Practice with experience of Fast efficient and effective Diagnosis of Sexual Health Issues
ffective Treatment Options
irect online Professional, Medical support 24/7
nnovation & constant research in Sexual health to continue to offer the latest options to our patients
linical Accuracy in Providing Medications –backed up –by a State of the Art Pharmacy
uthentic & secure medications & medical practices with Safety net
et us give you back the Best of times in your future Sexual life.
Call the Doctors at AMI Now For a Free Consultation & Enter into a Obligation Free Treatment Program
MORE THAN 500,000 PATIENTS HAVE ALREADY BEEN CONSULTED BY US
AMI operates a major modern centralised call center and 20 specialist medical clinics throughout Australia, New Zealand and China, and has more than 270 staff members, including more than 50 licensed medical personnel.
AMI - Assets
AMI operates a centralized call center throughout Australia, New Zealand and China.
o Patient profiles;
An Australian innovation patent (Australian Innovation Patent No 2005100183, which patent is due to expire on July 9, 2012), an Australian standard patent application (Australian standard patent application No. 2004222783), a worldwide PCT patent application Patent No PCT/AU2004/000931 (WO 2005/004855 A1)) filed with IP Australia and the subsequent individual country applications filed in the United States, Europe, Japan, the People’s Republic of China, India and New Zealand. The patents relate to various methods of treatment delivery via nasal (mucosal) inhalation and topical application of certain formulations used in AVMD’s treatments for premature ejaculation. The patents and associated formulations are integral to those treatments. AVMD’s impotence and erectile dysfunction treatments are not patent protected.